Assurance, tax, and advisory for pharmaceutical manufacturers, generics developers, CMOs/CDMOs, and R&D-focused companies. ASC 606, R&D credits, cGMP readiness.
Pharmaceutical companies operate in a highly regulated and competitive environment shaped by evolving FDA requirements, increasing development and manufacturing costs, pricing pressures, supply chain complexity, intellectual property considerations, and the need to accelerate speed to market. We work across multiple segments of the pharmaceutical industry, including commercial manufacturers supporting ANDA products, generic and specialty pharmaceutical developers, contract manufacturing organizations (CMOs/CDMOs), and research and development-focused companies. Our team of professionals brings extensive industry knowledge and understands the operational, regulatory, and financial challenges unique to the pharmaceutical sector. We provide strategic and practical solutions designed to support compliance, optimize operations, improve profitability, and help your organization maintain a competitive advantage.
RMG professionals maintain deep expertise in pharmaceutical accounting, regulatory compliance, and industry-specific tax strategy, enabling us to deliver specialized guidance across the full spectrum of pharma financial management.
Our Key Service Offerings
- ASC 606 Revenue Recognition for Contract Manufacturing
- Assurance Engagements (Audits, Reviews, Compilations)
- Internal Financial Reporting & Forecasting
- Inventory Valuation & Cost Accounting (FDA Environments)
- Profitability Analysis by Product Line & Facility
- Internal Controls for cGMP & SOX Readiness
- R&D Tax Credit Maximization (Section 41)
- Tax Strategy (Section 199A, IP Structuring, SALT)
- Preparation and maintenance of employee stock compensation schedules, including stock option tracking and vesting activity
- Cost Segregation & Bonus Depreciation Studies
- M&A Transaction Readiness & Due Diligence
